Add Yahoo as a preferred source to see more of our stories on Google. Apr. 9—(StatePoint) Pneumococcal pneumonia is a potentially serious bacterial lung disease that can disrupt your life for weeks ...

Merck's pneumococcal vaccine showed strong immune responses in children and teens who are at higher risk of serious illness in a late-stage study, the drugmaker said on Thursday. The shot, Capvaxive, ...

Add Yahoo as a preferred source to see more of our stories on Google. Less than half (44%) of eligible respondents said they planned to get a pneumococcal vaccine; fewer than one in four (24%) said ...

The Food and Drug Administration on Monday approved Merck’s new pneumococcal vaccine for adults 18 and older. The vaccine, which will be sold under the name Capvaxive, is designed to protect against ...

June 17 (Reuters) - Merck (MRK.N), opens new tab said on Monday the U.S. Food and Drug Administration has approved its next-generation vaccine to protect adults against the pneumococcal disease. The ...

In adults living with HIV, the 21-valent pneumococcal conjugate vaccine (PCV) V116 was well tolerated and effective against all 21 target serotypes. The immune responses were comparable to those ...

Pneumococcal pneumonia is a potentially serious bacterial lung disease that can disrupt your life for weeks and even land you in the hospital. Medical experts want you to know that there are steps you ...

Sept 11 (Reuters) - Merck's (MRK.N), opens new tab pneumococcal vaccine triggered immune responses in children and teens who are at higher risk of serious illness in a late-stage study, the drugmaker ...